Company Filing History:
1 out of 25 
1 out of 15 Years Active: 2023
Title: Nara Han: Innovating in Targeted Cancer Therapy
Introduction
Nara Han, an esteemed inventor based in Daejeon, South Korea, has made significant advancements in the field of targeted cancer therapies. His innovative work, encompassed in his patent, addresses critical needs in the treatment of various illnesses, particularly those associated with the over-expression of ROR1, a protein often linked to certain cancers.
Latest Patents
Nara Han holds a patent for an "Antibody-drug conjugate comprising antibody against human ROR1 and use for the same." This invention focuses on novel antibody-drug conjugates (ADCs) that specifically target ROR1. The patent details a process for preparing these ADCs and their pharmaceutical uses in treating or preventing diseases linked to ROR1 over-expression, notably cancer. The conjugate consists of an antibody that binds to ROR1 or its antigen-binding fragment, making it a crucial development in cancer research and therapy.
Career Highlights
Nara has contributed to significant advancements in biopharmaceutical research through his roles at companies such as Legochem Biosciences, Inc. and Abl Bio Inc. His work has not only showcased his expertise in antibody-drug conjugates but has also placed him at the forefront of innovative cancer treatment strategies.
Collaborations
Throughout his career, Nara Han has collaborated with talented individuals in the biopharmaceutical field, including prominent coworkers such as Yun-Hee Park and Ho Young Song. These collaborations have helped foster an environment of innovation and creativity, leading to the development of groundbreaking therapies aimed at improving patient outcomes.
Conclusion
Nara Han's contributions to the field of targeted cancer therapies highlight the importance of innovative research and collaborative efforts in developing effective treatment options. With his patent on antibody-drug conjugates targeting ROR1, he has paved the way for advancements that could transform the therapeutic landscape for cancer patients. His work serves as an inspiration for future inventors and researchers dedicated to making a difference in the medical field.